In ACS treated with drug-eluting stents and 3 mo of DAPT, ticagrelor monotherapy reduced clinical events at 1 y vs. DAPT.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 33075261.
- Also identified by DOI 10.7326/ACPJ202010200-043.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Kim BK, Hong SJ, Cho YH, et al. <b>Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome: the TICO randomized clinical trial.</b> JAMA. 2020;323:2407-16. 32543684.
Medical subject headings
- Acute Coronary Syndrome
- Drug-Eluting Stents
- Percutaneous Coronary Intervention